Does vitamin D have a role in reducing the risk of peripheral artery disease?

Mayo Clinic Proceedings

Volumn 85, Issue 11, 2010, Pages 1058-1059

  Mascitelli, Luca ^a   Goldstein, Mark R ^b   Grant, William B ^c  

^a Comando Brigata Alpina Julia ^*  (Italy)

^b Fountain Medical Court ^*  (United States)

^c Sunlight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ACTIN; ADENOSINE TRIPHOSPHATE; CALCITRIOL; COLLAGEN TYPE 1; ELASTIN; GELATINASE B; MYOSIN; TROPONIN C; VASCULOTROPIN; VITAMIN D; VITAMIN D RECEPTOR;

ARTERY DISEASE; CARDIOVASCULAR RISK; CLAUDICATION; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNICITY; HUMAN; HYPERTENSION; LETTER; MORBIDITY; MUSCLE STRENGTH; MYOPATHY; OBESITY; PAIN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SARCOPLASM; SUN EXPOSURE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 78149327920     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2010.0508     Document Type: Letter

References (5)

1. Olin JW, Sealove BA. Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc. 2010;85(7):678-692.
2. Melamed ML, Muntner P, Michos ED, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol. 2008;28(6):1179-1185.
3. Reis JP, Michos ED, von Mühlen D, Miller ER III. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr. 2008;88(6):1469-1477.
4. Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol. 2005;25(1):39-46.
5. Gilsanz V, Kremer A, Mo AO, Wren TA, Kremer R. Vitamin D status and its relation to muscle mass and muscle fat in young women. J Clin Endocrinol Metab. 2010;95(4):1595-1601.